The silencing of FXR1 leads to decreased cell growth and increased cell apoptosis ratio by destabilizing ECT2 mRNA.[3] Furthermore, FXR1 expression is elevated in squamous cell carcinoma of the head and neck. This evidence concerns the gene FXR1 and squamous cell carcinoma.